Sage Journals: Discover world-class research

Open access

Case report

First published 2018

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

Hope Cottrill, Stephanie Cason, Scott Caroen [...]

Journal of Investigative Medicine High Impact Case Reports

Retricted access

Research article

First published 2013-11

Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer

Paolo Piacentini, Filippo Greco, Anna Mercanti [...]

Tumori Journal

Open access

Research article

First published 2017-6

Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet

Yanjuan Xiong, Ning Zhao, Yu Zheng [...]

Tumor Biology

Open access

Case report

First published 2016

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient after Priming with RRx-001

Bryan Oronsky, Scott Caroen, Karen Zeman [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2024-6

Successful switch to cisplatin-based chemotherapy in a patient with lung cancer who developed a carboplatin-induced hypersensitivity reaction

Yuko Nagata, Gouji Toyokawa, Akiko Sugiyama [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2016-2

Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC

Hongxuan Zhou, Yun Dai, Liqun Zhu [...]

Journal of International Medical Research

Open access

Research article

First published 2021

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy

Jyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase [...]

Therapeutic Advances in Drug Safety

Free access

Research article

First published 2015-7

MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer

Kazuya Hiura, Akiko Shiraishi, Chinami Suzuki [...]

Cancer Biomarkers

Retricted access

Research article

First published 2018-12

Genetic Variants in the Wingless Antagonist Genes ( sFRP,DKK,and Axin2 ) Predict the Overall Survival and Prognosis of North Indian Lung Cancer Patients Treated with Platinum-Based Doublet Chemotherapy

Charu Bahl, Navneet Singh, Digambar Behera [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2025

TROPION-Lung15: a randomized phase III study of osimertinib combined with datopotamab deruxtecan (Dato-DXd) or Dato-DXd alone versus platinum-doublet chemotherapy in patients with EGFR -mutated advanced non-small cell lung cancer and whose disease has progressed on prior osimertinib

Daniel Shao-Weng Tan, Ernest Nadal, Parneet Cheema [...]

Therapeutic Advances in Medical Oncology

Search results